Kezar Life Sciences's total assets for Q1 2025 were $125.26M, a decrease of -13.42% from the previous quarter. KZR total liabilities were $22.19M for the fiscal quarter, a -20.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.